First participants join major UK trial to test Alzheimer’s treatments with CPFT

Cambridgeshire and Peterborough NHS Foundation Trust’s (CPFT) research team have helped the very first people take part in a new UK trial to speed up the search for effective Alzheimer’s disease treatments.

BioUK Awards 2026 celebrate outstanding achievement and breakthrough innovations from across the Life Sciences

Abingdon, UK - BioUK, the not-for-profit membership organisation focused on catalysing success in UK life sciences, announces the winners of the 18th annual BioUK Awards following a ceremony hosted at the Royal Lancaster Hotel, London.

Cambridge early-stage companies raise £9bn in a decade as average deal size grows five-fold

New analysis revealed at the Innovate Cambridge Summit shows average equity raised per deal rose fivefold, from £2m in 2015 to £10m in 2025Greater Cambridge led the UK in average life sciences and deep tech investment per deal in 2025, cementing its position as the world’s second mo

Raspberry PI corporate retreat at Barrington Hall

For the fifth consecutive year, Cambridge Dining Co. had the pleasure of delivering a seamless two-day corporate retreat for our valued client, Raspberry PI, hosted at our partner venue, Barrington Hall.

Eppendorf and BioLabs expand collaboration to support biotech innovation in Munich

•    The collaboration will provide laboratory equipment, technical support and engagement opportunities for BioLabs resident companies •    Builds on existing partnerships at BioLabs sites across the US, Germany and France

Takara Bio USA partners with SPT Labtech to deliver automation-ready NGS library preparation technologies

Trusted NGS chemistries from Takara Bio now optimized for firefly® automated workflows

ScionxBio announces collaboration to develop long-acting xRNA Therapeutics

Cambridge, UK, 20 October 2026: ScionxBio (the “company”, operating as a brand identity of Eleven Therapeutics Ltd.

Fashion fundraiser for Addenbrooke’s Charity spotlights secondary breast cancer

Bag a bargain. Inject some joy into your wardrobe. Support a great cause. Do all three at this weekend's Trash Chic charity sale. Taking place in the main mall of Cambridge’s Grand Arcade on Saturday, October 24, the event is being held in aid of Addenbrooke's Charity to support cancer services and help build the new Cambridge Cancer Research Hospital. It will also raise awareness of metastatic…

Qureight appointed imaging CRO for Phase 3 SURPASS-IPF trial as partnership with Celea Therapeutics expands

Celea has now contracted Qureight as the end-to-end imaging CRO for the phase 3 SURPASS-IPF trial, including Fibr8™ and four additional AI imaging models Joint poster at CHEST 2026 presents analysis completed as part of Qureight’s work on Celea’s phase 2b ELEVATE-I

Addenbrooke’s Charitable Trust wins Charity of the Year – and takes home four more awards – at the 2026 National Charity Today Awards

Addenbrooke’s Charitable Trust (ACT) has been crowned Charity of the Year at the 2026 National Charity Today Awards – widely recognised as the ‘Oscars’ of the charitable sector. ACT also topped the Fundraiser of the Year and public-voted People’s Choice Award categories, as well as being highly commended in Volunteer of the Year and PR Team of the Year. With three wins and two runner-up…

What a UK Healthcare Degree Represents

By Lily Lin, CEO, Excellence First Enterprise Consultancy (EFEC)

Expanded international IP protection for concentrated ultra-rapid acting insulins enabling next generation of Automated Insulin Delivery (AID) systems

Arecor Therapeutics plc, a clinical stage biotech company developing superior therapeutics to reduce treatment burden and improve outcomes for people living with diabetes, obesity and other cardiometabolic diseases, has strengthened its patent protection for the company

How do founders handle the people side of scaling? New Cambridge-based project to help scale-up leaders gain insights from peers

Founders and executives at Cambridge scale-ups are being invited to share how they’ve handled the people challenges of fast growth, as part of a new peer insights project.

PHG Foundation to become PHG Cambridge

PHG Foundation is changing its name to PHG Cambridge. The change will be in place from 21 October 2026.What is changingFrom 21 October 2026 you'll start seeing the new name reflected in our website and other communications.

British Equestrian backs East Anglian Air Ambulance’s Cambridge Air Base Appeal as charity passes halfway mark in bid to raise £8.2 million

British championship event rider, Bubby Upton, is backing East Anglian Air Ambulance’s Cambridge Air Base Appeal and sharing details of how the charity helped her following a serious riding accident in 2023 that almost left her paralysed. Bubby’s support comes as the charity passes the halfway mark in its £8.2 million fundraising appeal.

Leading life science organisations collaborate for second London Bio-Innovation Week

One Nucleus, SLAS, and ELRIG will connect their communities through cross-event networking and partnering opportunities during London Bio-Innovation Week

ROAR Events Agency appoints Alex Goldie to business development team

Cambridge agency expands its business development team with a focus on technology and life sciences clients CAMBRIDGE, UK, 12 October 2026 - ROAR Events Agency has appointed Alex Goldie to its business development team to develop new client relationships and support the agency's growth, initially focusing on Cambridge's technology and life sciences sectors.

Elevate MedTech relaunches its website

The new site reflects Elevate MedTech’s global reach and is organised around the path a device takes from concept to market.

Undecimal Bio launches with $18 million oversubscribed Seed financing to address ‘liver trap’ in siRNA therapeutic delivery

·  A spin-out focused on AI-enabled decoding of the deliverome

·  Proprietary synthetic biology platform identifies conjugates that target RNA medicines beyond the liver, with initial focus on renovascular disease

Mursla Bio publishes peer-reviewed validation of Tissue-Specific Extracellular Vesicle Platform for Liquid Biopsy

Study published in Journal of Extracellular Vesicles validates platform for new class of liquid biopsy: multiomic disease biology of living cells from a chosen tissue, starting with the liver Platform underpins FDA Breakthrough Device-designated EvoLiver™ and preci

Stronger minds, stronger teams: build resilience in just half a day

Promote Mental Health has launched a new workshop: The Resilient Mind and Body. This half day workshop combines the knowledge and skills of two highly trained professionals in psychology and nutrition Claire Harris (Promote Mental Health) and Bee Innes (Healthy Be Naturopathy). It covers practical science based strategies to help your people feel better, perform better and stay well. Check out…

Stryker and CMR Surgical announce strategic alliance to advance robotic-assisted surgery

Strategic alliance combines CMR Surgical’s established platform and robotics expertise with Stryker’s scale, customer relationships and commercial reach to accelerate growth of the Versius Surgical Robotic portfolio.

Whose move next?

By Lily Lin, CEO, Excellence First Enterprise Consultancy (EFEC), and Founder, CognateUK.

Google DeepMind’s Nature Study on Watermarking AI-Designed Proteins Validated with Carterra HT-SPR

New paper published in Nature shows watermarks can be embedded in AI-generated proteins without compromising function, confirmed with binding kinetics data from Carterra’s LSA-XT

Shared Party Night – Christmas 2026

An Après-Ski Christmas Celebration! This Christmas, swap the boardroom for the slopes and join us for an unforgettable Après-Ski celebration! ROAR Events Agency invites you to experience the magic of the mountains at our spectacular Shared Christmas Party Night, taking place on Friday 11th December 2026 at The Venue @ Quy Mill Hotel & Spa, Cambridge. Step into a stunning Alpine-inspired…